Neurocritical Care News

Presence of axonal phosphorylated transactive response DNA-binding protein 43, or pTDP-43, accumulation in intramuscular nerve bundles is a likely biomarker for patients diagnosed with ALS, according to a study published in JAMA Neurology.

One in four neurosurgery patients experience adverse events, of which 25% are attributable to human error, according to a study published in Brain and Spine.

Onset of seizures after stroke more than doubled the risk for dementia in young patients, according to a study published in Neurology.

Lacosamide monotherapy for the treatment of childhood epilepsy with centrotemporal spikes was well tolerated and resulted in significantly reduced seizures, according to a study published in Brain and Development.

Patients with young-onset dementia are at greater risk for hospitalization due to motor vehicle crash injury than those without dementia, according to a study published in JAMA Network Open.

Relapsing MS patients, as well as those with disability progression independent of relapse activity, experienced increased brain atrophy, specifically in the cerebral cortex, researchers reported in JAMA Neurology.

A significant increase in ICU admissions for adolescents aged 12 to 17 years with deliberate self-harm was reported in Australia during the COVID-19 pandemic, according to a study in JAMA Network Open.

Researchers observed no improvement in functional outcomes in patients with acute subdural hematoma who underwent surgical evacuation compared with initial conservative treatment, according to a study published in The Lancet Neurology.

Patients hospitalized for COVID-19 infection and those who survived other severe acute respiratory infections were at similarly higher risk for subsequent neuropsychiatric diagnoses and treatment, researchers reported in JAMA Psychiatry.

The FDA has approved Radicava ORS oral suspension for the treatment of adults with ALS.